Literature DB >> 9192758

Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site.

J F Dong1, G Sae-Tung, J A López.   

Abstract

The glycoprotein (GP) Ib-IX-V complex contains a high-affinity binding site for thrombin on the platelet surface with a poorly defined role in platelet activation by this agonist. Four polypeptides comprise the complex: GP Ib alpha, GP Ib beta, GP IX, and GP V. The site within the complex that binds thrombin has been localized to a 45-kD region at the amino terminus of GP Ib alpha, which also contains the site through which the complex interacts with von Willebrand factor. A GP Ib-IX complex that lacks GP V can be efficiently expressed on the surface of transfected cells. We examined the ability of L cells expressing the GP Ib-IX complex (L2H cells) to bind thrombin at high affinity, and found no increase over the level of thrombin binding to control L cells. Because it is one of the few substrates for thrombin on the platelet surface, GP V has also been implicated as possibly participating in thrombin's actions on the platelet. To examine the role of GP V in forming the high-affinity thrombin-binding site, we compared the binding of thrombin to L2H cells versus cells that express the entire GP Ib-IX-V complex (L2H/V cells). Surface expression of GP Ib alpha was equivalent in these two stable cell lines. Thrombin binding to L2H/V cells was detectable at 0.25 nmol/L thrombin and reached a plateau at 1 nmol/L. No binding to L2H cells was detectable at these concentrations. Comparable results were obtained when thrombin binding to L2H cells transiently expressing GP V was compared with its binding to sham-transfected L2H cells. Again, only cells transiently expressing GP V bound thrombin specifically. As with the platelet polypeptide, thrombin cleaved GP V from the surface of L2H/V cells. To test whether GP V cleavage was required for enhancing thrombin binding to the complex, we tested the binding of enzymatically inactive D-phenylalanyl-L-prolyl-L-arginine chloromethylketone (PPACK)-thrombin to L2H and L2H/V cells. Like native thrombin, PPACK-thrombin at 1 nmol/L bound only to L2H/V cells, indicating that GP V cleavage is not a prerequisite for the formation of the high-affinity thrombin receptor. These data provide the first indication of a physiologic function for GP V, and suggest that formation of the high-affinity thrombin receptor on the platelet surface has complex allosteric requirements.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192758

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.

Authors:  Maneesh Arya; Anatoly B Kolomeisky; Gabriel M Romo; Miguel A Cruz; José A López; Bahman Anvari
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

Review 3.  Platelet GP Ib/IX/V complex: physiological role.

Authors:  J Rivera; M L Lozano; J Corral; R González-Conejero; C Martínez; V Vicente
Journal:  J Physiol Biochem       Date:  2000-12       Impact factor: 4.158

4.  Assessment of Time-Dependent Platelet Activation Using Extracellular Vesicles, CD62P Exposure, and Soluble Glycoprotein V Content of Platelet Concentrates with Two Different Platelet Additive Solutions.

Authors:  Sami Valkonen; Birte Mallas; Ulla Impola; Anne Valkeajärvi; Juha Eronen; Kaija Javela; Pia R-M Siljander; Saara Laitinen
Journal:  Transfus Med Hemother       Date:  2019-05-07       Impact factor: 3.747

Review 5.  Biomarkers of atherosclerosis and the potential of MRI for the diagnosis of vulnerable plaque.

Authors:  E Canet-Soulas; D Letourneur
Journal:  MAGMA       Date:  2007-06-29       Impact factor: 2.310

6.  Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia.

Authors:  Suthesh Sivapalaratnam; Sarah K Westbury; Jonathan C Stephens; Daniel Greene; Kate Downes; Anne M Kelly; Claire Lentaigne; William J Astle; Eric G Huizinga; Paquita Nurden; Sofia Papadia; Kathelijne Peerlinck; Christopher J Penkett; David J Perry; Catherine Roughley; Ilenia Simeoni; Kathleen Stirrups; Daniel P Hart; R Campbell Tait; Andrew D Mumford; Michael A Laffan; Kathleen Freson; Willem H Ouwehand; Shinji Kunishima; Ernest Turro
Journal:  Blood       Date:  2016-11-14       Impact factor: 22.113

7.  Leptin-Notch axis impairs 5-fluorouracil effects on pancreatic cancer.

Authors:  Adriana Harbuzariu; Ruben Rene Gonzalez-Perez
Journal:  Oncotarget       Date:  2018-04-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.